Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONS1G244 is an inhibitor of dipeptidyl peptidase 8 (DPP-8) and DPP-9 (IC50s = 14 and 53 nM, respectively).1 It is selective for DPP-8 and DPP-9 over DPP-4, DPP-2, and fibroblast activation protein (FAP; IC50s = >100 µM for all). 1G244 (20 µM) inhibits the differentiation of 3T3-L1 cells into adipocytes.2 It induces caspase-1-dependent pyroptosis in RAW 264.7 macrophages when used at a concentration of 10 µM.3 1G244 (2 mg/kg) decreases atherosclerotic lesion area and M1-like macrophage plaque infiltration in apoE-/- mice in a model of atherosclerosis induced by a high-fat diet.4
WARNING This product is not for human or veterinary use.
1. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem. Pharmacol. 78(2), 203-210 (2009).
2. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. Sci. Rep. 5(12348), 1-11 (2015).
3. DPP8 and DPP9 inhibition induces pro-
4. The antiatherosclerotic action of 1G244 -